AJMCOvjeren akaunt

@AJMC_Journal

The American Journal of is a peer-reviewed, indexed publication reaching more than 40,000 managed care executives.

Vrijeme pridruživanja: srpanj 2009.

Tweetovi

Blokirali ste korisnika/cu @AJMC_Journal

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AJMC_Journal

  1. Prikvačeni tweet
    15. sij

    New year, new look! We’re kicking off the 25th year of with our popular issue, including a talk with to launch the interview series.

    Poništi
  2. Novel Technology Found to Distinguish Between Disease, Multiple System Atrophy Learn more:

    Poništi
  3. On April 3rd, will offer a live training session at our Cranbury, New Jersey office that will allow unparalleled access to experts covering the use of healthcare info and development of contracting Register below!

    Poništi
  4. Watch as Dr. Joshua Ofman, chief of Corporate Strategy and External Affairs at , Discusses How Improving Survival, Reducing Costs in Vital to Value-Based Care Transition

    Poništi
  5. What We're Reading: Testing in ; Use; Emergency Use Authorization

    Poništi
  6. proslijedio/la je Tweet

    Reference-based drug pricing increased the use of lower-cost therapies, according to new study.

    Poništi
  7. Exchanging Data: A Look at 3 Standards Competing to Provide Interoperability Read from contributor Brenda Hopkins, Chief of Health Information Officer of

    Poništi
  8. 4. velj

    Experts Warn of Outbreak in Detention Centers

    Poništi
  9. 4. velj

    Although more than twice as many options for antiretroviral treatment (ART) were available in 2018 as were offered in 2012, between 2012 and 2018, the average wholesale price for initial jumped 34% for most people with Learn more:

    Poništi
  10. 4. velj

    "Ibrutinib quickly became the de fact standard of care to treat chronic lymphocytic leukemia, but the high price presents a problem for the US healthcare system." Watch as Dr Adam Olszewski Discusses Growing Ibrutinib Use to Treat CLL

    Poništi
  11. proslijedio/la je Tweet
    4. velj
    Poništi
  12. 4. velj

    What We're Reading: Launches Drug Database; HIV Trial Fails; NJ Enacts Task Force

    Poništi
  13. 4. velj

    Read as Dr. Simon Murray, chief medical officer for , provides his thoughts on the 2020-2025 Federal Health IT Strategic Plan draft issued by

    Poništi
  14. 3. velj

    Watch as Explains How Patients With Disabilities Experience Care Differently

    Poništi
  15. 3. velj

    What We're Reading: US Declares a Public Health Emergency; Approves Peanut Allergy Drug ; California Healthcare Tax Rejected

    Poništi
  16. 3. velj

    Discovery Could Enable Effective Treatments for Disease Learn more:

    Poništi
  17. proslijedio/la je Tweet
    3. velj
    Poništi
  18. 3. velj

    PAPER OF THE WEEK: This week's paper from our editors-in-chief, and , presented the idea of tying a prescription drug's cost-sharing to its clinical value to the patient Read it here!

    Poništi
  19. 2. velj
    Poništi
  20. 2. velj

    Participants Are Willing to Take On 2-Sided Risk, Finds Learn more:

    Poništi
  21. 2. velj

    ICYMI: Participants Are Willing to Take On 2-Sided Risk, Finds

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·